摘要
目的探析老年肺气肿合并感染应用头孢呋辛钠与清开灵联合疗法的临床效果研究。方法入选我院2013年1月—2013年12月老年肺气肿合并感染患者104例,按治疗方式的不同分入两组,每组52例。在常规治疗基础上,观察组施行头孢呋辛钠与清开灵联合疗法,对照组仅进行头孢呋辛钠疗法,观察两组的临床效果、临床症状缓解时间及不良反应情况。结果观察组、对照组的临床有效率分别为92.3%、75.0%,差异具有统计学意义(P<0.05);观察组的喘息、咳嗽、啰音、X线平片恢复情况显著优于对照组,差异具有统计学意义(P<0.05),治疗后观察组、对照组的不良反应的发生率分别为7.6%、23.0%,差异具有统计学意义(P<0.05)。结论老年肺气肿合并感染患者进行头孢呋辛钠与清开灵联合疗法,可有效促进患者病情康复,临床效果确切,可靠安全,值得临床推广。
Objective To discuss and analyze the clinical effect of cefuroxime sodium combined qingkailing for treatment of senile emphysema combined infection. Methods 104 patients with senile emphysema combined infection during January 2013 to December 2013 were chosen and divided into 2 groups each with 52 cases according to different treatment methods. On basis of routine treatment, observation group was given cefuroxime sodium combined qingkailing while control group was just given cefuroxime sodium. Clinical effect, relieving time of clinical symptoms and adverse reactions of the 2 groups were observed. Results Clinical effective rate of observation group and control group was separately 92.3% and 75.0%(P〈0.05); conditions of asthma, cough, rale and X-ray recovery were obviously superior to control group(P〈0.05);occurrence rate of adverse reactions of observation group and control group was separately 7.6% and 23.0%(P〈0.05). Conclusion Cefuroxime sodium combined qingkailing for treatment of senile emphysema combined infection can effectively promote rehabilitation of patients. It has an accurate and safe effect, so it is worth of being popularized clinically.
出处
《中国卫生产业》
2014年第22期24-25,共2页
China Health Industry
关键词
临床效果
老年肺气肿合并感染
清开灵
头孢呋辛钠
Clinical Effect
Senile Emphysema Combined Infection
Qingkailing
Cefuroxime Sodium